CYP 293 (Extuss LA 30 mg-650 mg)
Generic Name: dextromethorphan/guaifenesin
Pill imprint CYP 293 has been identified as Extuss LA 30 mg-650 mg.
Extuss LA is used in the treatment of expectoration; cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Extuss LA 30 mg-650 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- CYP 293
- 30 mg-650 mg
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Cypress Pharmaceutical Inc
More about Extuss LA (dextromethorphan / guaifenesin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.